Amedeo Smart

Free Medical Literature Service



Stem Cell Research

  Free Subscription

Articles published in
    September 2021
  1. ANU P, Antti T, Raija S, Marja P, et al
    Comparison of CD34(+) cell mobilization, blood graft cellular composition, and post-transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low-dose cyclophosphamide: A prospective multicenter study.
    Transfusion. 2021 Sep 9. doi: 10.1111/trf.16645.
    >> Share

    August 2021
  2. TANHEHCO YC, Delgado AC
    Red blood cell reduction of a sickle cell disease stem cell product.
    Transfusion. 2021 Aug 29. doi: 10.1111/trf.16633.
    >> Share

  3. GOEL R, Nellis ME, Karam O, Hanson SJ, et al
    Transfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: Data from the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).
    Transfusion. 2021 Aug 29. doi: 10.1111/trf.16626.
    >> Share

  4. HUVAROVA L, Koristek Z, Jelinek T, Cerna L, et al
    Washing transplants with Sepax 2 reduces the incidence of side effects associated with autologous transplantation and increases patients' comfort.
    Transfusion. 2021;61:2430-2438.
    >> Share

    May 2021
  5. PHAM HP, Dormesy S, Wolfe K, Budhai A, et al
    Potentially modifiable predictors of cell collection efficiencies and product characteristics of allogeneic hematopoietic progenitor cell collections.
    Transfusion. 2021;61:1518-1524.
    >> Share

  6. JACOB RP, Walsh EM, Maslak PG, Giralt SA, et al
    A simplified CD34+ based preharvest prediction tool for HPC(A) collection.
    Transfusion. 2021;61:1525-1532.
    >> Share

    April 2021
    A monthly roundup of key articles in other journals.
    Transfusion. 2021;61:1007-1009.
    >> Share

    March 2021
  8. RENNERT W, Sobh L, Cormier K, Smith J, et al
    The impact of donor total estimated blood volume on nucleated cell yield in bone marrow harvests for hematopoietic stem cell transplantation.
    Transfusion. 2021 Mar 25. doi: 10.1111/trf.16374.
    >> Share

  9. GASIOR M, Ferreras C, de Paz R, Bueno D, et al
    The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naive T-cell-depleted allogeneic stem cell transplantation.
    Transfusion. 2021 Mar 13. doi: 10.1111/trf.16354.
    >> Share

  10. CUZZUBBO D, Pegoraro F, Frenos S, Casini T, et al
    Planned haematopoietic stem cell transplantation in a 17-month-old patient with high-risk acute myeloid leukaemia and persistent SARS-CoV-2 infection.
    Transfusion. 2021 Mar 8. doi: 10.1111/trf.16361.
    >> Share

    A monthly roundup of key articles in other journals.
    Transfusion. 2021;61:665-668.
    >> Share

    February 2021
  12. BELISARIO AR, da Costa Funes AP, Luz JR, de Almeida Costa L, et al
    Influence of laboratory procedures on postthawing cell viability and hematopoietic engraftment after autologous peripheral blood stem cell transplantation.
    Transfusion. 2021 Feb 10. doi: 10.1111/trf.16289.
    >> Share

  13. YATES B, Molloy E, Dulau-Florea A, Braylan R, et al
    Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation.
    Transfusion. 2021 Feb 2. doi: 10.1111/trf.16281.
    >> Share

    January 2021
  14. BHUNIA N, Abu-Arja R, Stanek JR, Shaw PJ, et al
    A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disorders.
    Transfusion. 2021 Jan 21. doi: 10.1111/trf.16260.
    >> Share

  15. KHAN J, Dunbar NM
    Time to stop worrying about ABO incompatible cryoprecipitate transfusions in adults.
    Transfusion. 2021;61:1-4.
    >> Share

    December 2020
  16. LI EW, Lee A, Vaseghi-Shanjani M, Anagnostopoulos A, et al
    Multimedia resources to support the recruitment of committed hematopoietic stem cell donors: Perspectives of the most-needed donors.
    Transfusion. 2020 Dec 2. doi: 10.1111/trf.16186.
    >> Share

    November 2020
  17. PARTANEN A, Turunen A, Valtola J, Pyorala M, et al
    Mobilization characteristics, blood graft composition, and outcome in diffuse large B-cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study.
    Transfusion. 2020 Nov 27. doi: 10.1111/trf.16198.
    >> Share

    October 2020
  18. ENOK BONONG PR, Buteau C, Delage G, Tanner JE, et al
    Transfusion-related Epstein-Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study).
    Transfusion. 2020 Oct 22. doi: 10.1111/trf.16149.
    >> Share

  19. MONAGHAN M, Yi QL, Green M, Campbell T, et al
    Factors associated with registrant availability for unrelated adult donor hematopoietic stem cell donation: Analysis of the stem cell registry at Canadian Blood Services.
    Transfusion. 2020 Oct 21. doi: 10.1111/trf.16129.
    >> Share

  20. STEUER LV, Kondo AT, Cipolletta AN, Sakashita AM, et al
    Predictive factors for the development of anemia after hematopoietic stem cell donation.
    Transfusion. 2020 Oct 14. doi: 10.1111/trf.16124.
    >> Share

    September 2020
  21. NIZZI F, Rees M, Salzberg D, Ngwube A, et al
    Successful management of sirolimus toxicity in a hematopoietic stem cell transplant patient using automated red blood cell exchange.
    Transfusion. 2020 Sep 5. doi: 10.1111/trf.16064.
    >> Share

    August 2020
  22. RHEAUME ME, Rouleau P, Tremblay T, Pare I, et al
    Short-Term exposure of umbilical cord blood CD34+ cells to human platelet lysate and cytokines enhances engraftment.
    Transfusion. 2020 Aug 5. doi: 10.1111/trf.15991.
    >> Share

    June 2020
  23. MARINELLI BUSILACCHI E, Costantini A, Mancini G, Bencivenga R, et al
    A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation.
    Transfusion. 2020 Jun 2. doi: 10.1111/trf.15825.
    >> Share

  24. ZHUANG L, Boriboonnangkul P, Wang S, Yuan S, et al
    Third time's a charm? Mobilization of autologous peripheral blood stem cells in patients with two previous failed mobilizations with plerixafor.
    Transfusion. 2020 Jun 1. doi: 10.1111/trf.15853.
    >> Share

    May 2020
  25. IKEDA K, Ohto H, Yamada-Fujiwara M, Okuyama Y, et al
    Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.
    Transfusion. 2020;60:1015-1023.
    >> Share

    April 2020
  26. TURUNEN A, Partanen A, Valtola J, Ropponen A, et al
    CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter Goa study.
    Transfusion. 2020 Apr 24. doi: 10.1111/trf.15820.
    >> Share

  27. LEITNER GC, Ho M, Tolios A, Hopfinger G, et al
    The assessment of platelet function by thromboelastometry as a point-of-care test to guide Intercept-treated platelet support in hemato-oncological patients and hematopoietic stem cell transplantation recipients.
    Transfusion. 2020 Apr 22. doi: 10.1111/trf.15783.
    >> Share

    March 2020
  28. JAHAN S, Adam MK, Manesia JK, Doxtator E, et al
    Inhibition of ice recrystallization during cryopreservation of cord blood grafts improves platelet engraftment.
    Transfusion. 2020 Mar 18. doi: 10.1111/trf.15759.
    >> Share

    February 2020
  29. ROTH H, Schneider L, Eberle R, Lausen J, et al
    Zika virus infection studies with CD34(+) hematopoietic and megakaryocyte-erythroid progenitors, red blood cells and platelets.
    Transfusion. 2020 Feb 22. doi: 10.1111/trf.15692.
    >> Share

  30. CID J, Castillo C, Marin P, Carbasse G, et al
    Increased collection efficiency of CD34+ cells after mobilization with preemptive use of plerixafor followed by leukocytapheresis on the same day.
    Transfusion. 2020 Feb 17. doi: 10.1111/trf.15711.
    >> Share

  31. YUAN S, Zhuang L, Stinson S, Barton P, et al
    Red cell clumping in stem cell collection bag.
    Transfusion. 2020 Feb 16. doi: 10.1111/trf.15719.
    >> Share

  32. LIAO G, Gilmore K, Steed A, Elmoazzen H, et al
    Willingness of volunteers from Canadian Blood Service's Stem Cell Registry to donate blood, marrow, and other tissues for regenerative therapy.
    Transfusion. 2020 Feb 10. doi: 10.1111/trf.15695.
    >> Share

    January 2020
  33. SEIKE K, Fujii N, Asano N, Ohkuma S, et al
    Efficacy of HLA virtual cross-matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation.
    Transfusion. 2020 Jan 22. doi: 10.1111/trf.15664.
    >> Share

  34. AFZAL A, Tarbunova M, Despotis G, Grossman BJ, et al
    The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD).
    Transfusion. 2020 Jan 9. doi: 10.1111/trf.15653.
    >> Share

  35. HUSSEIN E, DeFor T, Wagner JE, Sumstad D, et al
    Evaluation of post-thaw CFU-GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant.
    Transfusion. 2020;60:144-154.
    >> Share

  36. YOON EJ, Zhang J, Weinberg RS, Brochstein JA, et al
    Validation of simple prediction algorithms to consistently achieve CD3+ and postselection CD34+ targets with leukapheresis.
    Transfusion. 2020;60:133-143.
    >> Share

    October 2019
  37. VELIER M, Granata A, Bramanti S, Calmels B, et al
    A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution.
    Transfusion. 2019 Oct 18. doi: 10.1111/trf.15545.
    >> Share

  38. YUAN S, Yang D, Nakamura R, Zhuang L, et al
    RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantation.
    Transfusion. 2019 Oct 10. doi: 10.1111/trf.15531.
    >> Share

    September 2019
  39. TAJIMA K, Takizawa K, Yasuda T, Tsumanuma R, et al
    Characterization of reemergent anti-B red blood cell antibodies in a patient with recurrent acute myeloid leukemia with ABO-incompatible allogeneic peripheral blood stem cell transplantation.
    Transfusion. 2019 Sep 10. doi: 10.1111/trf.15510.
    >> Share

    July 2019
  40. BHOWMICK T, Rasool A, Desai A, Weinstein MP, et al
    Erythema migrans spares rash of engraftment syndrome.
    Transfusion. 2019;59:2193-2194.
    >> Share

    June 2019
  41. WARNER MA, Jambhekar NS, Saadeh S, Jacob EK, et al
    Implementation of a patient blood management program in hematopoietic stem cell transplantation.
    Transfusion. 2019 Jun 20. doi: 10.1111/trf.15414.
    >> Share

    May 2019
  42. CID J, Carbasse G, Suarez-Lledo M, Moreno DF, et al
    Efficacy and safety of one-day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft-versus-host disease.
    Transfusion. 2019 May 28. doi: 10.1111/trf.15384.
    >> Share

  43. AKEL S, Murray C, Ferguson W, Babic A, et al
    Outcomes of processing of bone marrow harvests for hematopoietic stem cell transplantation in pediatric patients utilizing a novel red blood cell sedimentation kit.
    Transfusion. 2019 May 8. doi: 10.1111/trf.15337.
    >> Share

  44. LAMARCHE MC, Hammond DE, Hopman WM, Sirosky-Yanyk A, et al
    Can we transfuse wisely in patients undergoing chemotherapy for acute leukemia or autologous stem cell transplantation?
    Transfusion. 2019 May 6. doi: 10.1111/trf.15335.
    >> Share

    April 2019
  45. GASTECKI K, Shanley R, Welbig J, Cohn C, et al
    Red blood cell product utilization in patients undergoing allogeneic stem cell transplantation.
    Transfusion. 2019 Apr 8. doi: 10.1111/trf.15285.
    >> Share

  46. CHRISTY BA, Herzig MC, Delavan C, Cantu C, et al
    Human primary fibroblasts perform similarly to MSCs in assays used to evaluate MSC safety and potency.
    Transfusion. 2019;59.
    >> Share

    March 2019
  47. KANG J, Hong JY, Yoon DH, Kim JE, et al
    Pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization: a prospective randomized study for optimal apheresis.
    Transfusion. 2019 Mar 29. doi: 10.1111/trf.15265.
    >> Share

  48. VIAU S, Eap S, Chabrand L, Lagrange A, et al
    Viral inactivation of human platelet lysate by gamma irradiation preserves its optimal efficiency in the expansion of human bone marrow mesenchymal stromal cells.
    Transfusion. 2019;59:1069-1079.
    >> Share

    February 2019
  49. JONES RE, Foster DS, Hu MS, Longaker MT, et al
    Wound healing and fibrosis: current stem cell therapies.
    Transfusion. 2019;59.
    >> Share

  50. FIERRO FA, Magner N, Beegle J, Dahlenburg H, et al
    Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions.
    Transfusion. 2019;59.
    >> Share

  51. HUPPERT LA, Liu KD, Matthay MA
    Therapeutic potential of mesenchymal stromal cells in the treatment of ARDS.
    Transfusion. 2019;59.
    >> Share

  52. GODBEY EA, Dormesy S, Gowda L, Nandi V, et al
    A dual strategy to optimize hematopoietic progenitor cell collections: validation of a simple prediction algorithm and use of collect flow rates guided by mononuclear cell count.
    Transfusion. 2019;59:659-670.
    >> Share

    January 2019
  53. DOBERSCHUETZ N, Soerensen J, Bonig H, Willasch A, et al
    Mobilized peripheral blood stem cell apheresis via Hickman catheter in pediatric patients.
    Transfusion. 2019 Jan 4. doi: 10.1111/trf.15113.
    >> Share

    A monthly roundup of key articles in other journals.
    Transfusion. 2019;59:12-14.
    >> Share

    December 2018
  55. ONO Y, Yoshioka S, Inoue K, Yoshida M, et al
    Stochastic model based on preharvest peripheral CD34-positive cell count and collection efficiency predicting processed blood volume in peripheral hematopoietic stem cell apheresis.
    Transfusion. 2018 Dec 28. doi: 10.1111/trf.15096.
    >> Share

  56. ROHNER N, Passweg JR, Tsakiris DA, Halter JP, et al
    The value of the post-thaw CD34+ count with and without DMSO removal in the setting of autologous stem cell transplantation.
    Transfusion. 2018 Dec 17. doi: 10.1111/trf.15107.
    >> Share

  57. DE GREEF GE, Braakman E, van der Holt B, Janssen JJWM, et al
    The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study.
    Transfusion. 2018 Dec 11. doi: 10.1111/trf.15037.
    >> Share

  58. GALEL D, Crisostomo C, Ortega J, Peters K, et al
    Nucleated red blood cells as a novel indicator of CD34(+) cell content in umbilical cord blood.
    Transfusion. 2018 Dec 7. doi: 10.1111/trf.15080.
    >> Share

  59. MUNIZ ALERS SM, Page K, Simmons R, Waters-Pick B, et al
    Automated thawing increases recovery of colony-forming units from banked cord blood unit grafts.
    Transfusion. 2018;58:2911-2917.
    >> Share

    November 2018
  60. QUEK J, Lee JJ, Lim FL, Diong C, et al
    Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant.
    Transfusion. 2018 Nov 22. doi: 10.1111/trf.15053.
    >> Share

  61. PARTANEN A, Valtola J, Ropponen A, Kuitunen H, et al
    Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34(+) cells in non-Hodgkin lymphoma patients.
    Transfusion. 2018 Nov 19. doi: 10.1111/trf.14993.
    >> Share

  62. LEE JH, Park J, Lee JW
    Therapeutic use of mesenchymal stem cell-derived extracellular vesicles in acute lung injury.
    Transfusion. 2018 Nov 1. doi: 10.1111/trf.14838.
    >> Share

  63. CHOU ST
    "Rare" reagent red cells: rare no longer?
    Transfusion. 2018;58:2469-2471.
    >> Share

  64. KIKUCHI G, Kurita R, Ogasawara K, Isa K, et al
    Application of immortalized human erythroid progenitor cell line in serologic tests to detect red blood cell alloantibodies.
    Transfusion. 2018;58:2675-2682.
    >> Share

    October 2018
  65. GRIFFITH LM, VanRaden M, Barrett AJ, Childs RW, et al
    Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993-2010): factors that predict intensity and time to transfusion independence.
    Transfusion. 2018 Oct 26. doi: 10.1111/trf.14966.
    >> Share

  66. VERDU-AMOROS J, Woessmann W, Maecker-Kolhoff B, Schulz A, et al
    Mini photopheresis for refractory chronic graft-versus-host disease in children and adolescents.
    Transfusion. 2018 Oct 6. doi: 10.1111/trf.14880.
    >> Share

    September 2018
  67. IEMURA T, Itoh M, Mano C, Oba A, et al
    Successful engraftment after cord blood transplantation from an HLA-homozygous donor (homo-to-hetero cord blood transplantation) in a primary myelofibrosis patient with broad HLA antibodies.
    Transfusion. 2018 Sep 28. doi: 10.1111/trf.14885.
    >> Share

  68. KLEINMAN S, Stassinopoulos A
    Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied intervention.
    Transfusion. 2018 Sep 28. doi: 10.1111/trf.14930.
    >> Share

  69. INIESTA P, Revilla N, Chen-Liang TH, Hurtado AM, et al
    An early increase of CD56(bright) natural killer subset as dominant effect and predictor of response to extracorporeal photopheresis for graft-versus-host disease.
    Transfusion. 2018 Sep 27. doi: 10.1111/trf.14964.
    >> Share

  70. ARLT N, Rothe R, Sielaff S, Juretzek T, et al
    Sterility release testing of peripheral blood stem cells for transplantation: impact of culture bottles and incubation temperature.
    Transfusion. 2018 Sep 27. doi: 10.1111/trf.14910.
    >> Share

  71. RUSSELL AL, Lefavor RC, Zubair AC
    Characterization and cost-benefit analysis of automated bioreactor-expanded mesenchymal stem cells for clinical applications.
    Transfusion. 2018 Sep 10. doi: 10.1111/trf.14805.
    >> Share

  72. ALVA LC, Bacher U, Seipel K, Mansouri Taleghani B, et al
    Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia.
    Transfusion. 2018 Sep 10. doi: 10.1111/trf.14895.
    >> Share

  73. HESS J, Su L, Nizzi F, Beebe K, et al
    Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept.
    Transfusion. 2018 Sep 4. doi: 10.1111/trf.14907.
    >> Share

  74. TAKANASHI M, Selogie E, Reems JA, Stroncek D, et al
    Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
    Transfusion. 2018;58:2184-2191.
    >> Share

    July 2018
  75. SPOERL S, Wascher D, Nagel S, Peschel C, et al
    Evaluation of the new continuous mononuclear cell collection protocol versus an older version on two different apheresis machines.
    Transfusion. 2018;58:1772-1780.
    >> Share

    May 2018
  76. AHN H, Tay J, Shea B, Hutton B, et al
    Effectiveness of immunoglobulin prophylaxis in reducing clinical complications of hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Transfusion. 2018 May 16. doi: 10.1111/trf.14656.
    >> Share

  77. SIEGEL G, Fleck E, Elser S, Hermanutz-Klein U, et al
    Manufacture of endothelial colony-forming progenitor cells from steady-state peripheral blood leukapheresis using pooled human platelet lysate.
    Transfusion. 2018;58:1132-1142.
    >> Share

    April 2018
  78. NIITTYVUOPIO R, Juvonen E, Heiskanen J, Lindstrom V, et al
    Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: a single-center experience.
    Transfusion. 2018 Apr 29. doi: 10.1111/trf.14649.
    >> Share

  79. MINAKAWA K, Ohto H, Yasuda H, Saito S, et al
    Efficacy of D- red blood cell transfusion and rituximab therapy in autoimmune hemolytic anemia with anti-D and panreactive autoantibodies arising after hematopoietic stem cell transplant.
    Transfusion. 2018 Apr 17. doi: 10.1111/trf.14634.
    >> Share

  80. CASTRO G, Merkel PA, Giclas HE, Gibula A, et al
    Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease.
    Transfusion. 2018 Apr 2. doi: 10.1111/trf.14589.
    >> Share

    March 2018
  81. RUSSELL AL, Lefavor R, Durand N, Glover L, et al
    Modifiers of mesenchymal stem cell quantity and quality.
    Transfusion. 2018 Mar 26. doi: 10.1111/trf.14597.
    >> Share

  82. BOJANIC I, Mravak Stipetic M, Pulanic D, Desnica L, et al
    Autologous blood as a source of platelet gel for the effective and safe treatment of oral chronic graft-versus-host disease.
    Transfusion. 2018 Mar 14. doi: 10.1111/trf.14594.
    >> Share

  83. WANG T, Remberger M, Axdorph Nygell U, Sundin M, et al
    Change of apheresis device decreased the incidence of severe acute graft-versus-host disease among patients after allogeneic stem cell transplantation with sibling donors.
    Transfusion. 2018 Mar 13. doi: 10.1111/trf.14579.
    >> Share

    February 2018
  84. MARCHESI F, Vacca M, Giannarelli D, Ipsevich F, et al
    Lenograstim 5 microg/kg is not superior to biosimilar filgrastim 10 microg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study.
    Transfusion. 2018 Feb 15. doi: 10.1111/trf.14533.
    >> Share

  85. WOREL N, Lehner E, Fuhrer H, Kalhs P, et al
    Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?
    Transfusion. 2018 Feb 15. doi: 10.1111/trf.14506.
    >> Share

  86. REICH-SLOTKY R, Cushing MM, Hsu YS, Ancharski M, et al
    Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience.
    Transfusion. 2018;58:339-344.
    >> Share

  87. PARK G, Shayani S, Stiller T, Wang S, et al
    Dose capping of plerixafor in patients weighing more than 100 kg at one vial led to successful mobilization outcomes and significant cost savings.
    Transfusion. 2018;58:323-329.
    >> Share

    December 2017
  88. ZHU J, Huang H, Chen H, Zhang X, et al
    Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkin's lymphoma: a randomized Phase 3 study.
    Transfusion. 2017 Dec 13. doi: 10.1111/trf.14426.
    >> Share

  89. VILLA CH, Porturas T, Sell M, Wall M, et al
    Rapid prediction of stem cell mobilization using volume and conductivity data from automated hematology analyzers.
    Transfusion. 2017 Dec 11. doi: 10.1111/trf.14449.
    >> Share

  90. PIERCE J, Benedetti E, Preslar A, Jacobson P, et al
    Comparative analyses of industrial-scale human platelet lysate preparations.
    Transfusion. 2017;57:2858-2869.
    >> Share

    November 2017
  91. PIERELLI L, Bosi A, Olivieri A
    "Best practice" for extracorporeal photopheresis in acute and chronic graft-versus-host disease by Societa' Italiana di Emaferesi and Manipolazione Cellulare and Gruppo Italiano Trapianto Midollo Osseo: a national survey to ascertain its degree of app
    Transfusion. 2017 Nov 13. doi: 10.1111/trf.14400.
    >> Share

  92. SOURI M, Nikougoftar Zarif M, Rasouli M, Golzadeh K, et al
    Comparison of human umbilical cord blood processing with or without hydroxyethyl starch.
    Transfusion. 2017;57:2758-2766.
    >> Share

    September 2017
  93. FINGRUT W, Parmar S, Cuperfain A, Rikhraj K, et al
    The Stem Cell Club: a model for unrelated stem cell donor recruitment.
    Transfusion. 2017 Sep 24. doi: 10.1111/trf.14327.
    >> Share

    July 2017
  94. ALBANO MS, Ciubotariu R, Dobrila L, Tarnawski M, et al
    Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potency.
    Transfusion. 2017 Jul 31. doi: 10.1111/trf.14257.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016